Department of Surgery, Division of Urology, San Paolo Hospital, Savona, Italy.
BJU Int. 2011 Oct;108(7):1140-4. doi: 10.1111/j.1464-410X.2010.09994.x.
• To retrospectively report the objective and subjective outcomes of suburethral tension adjustable sling (Remeex system) implantation for stress urinary incontinence (SUI) caused by 'true' intrinsic sphincter deficiency (ISD) with fixed urethra.
• Thirty female patients with severe SUI, mainly because of iatrogenic ISD, underwent Remeex system positioning between May 2002 and July 2008 (mean follow-up 60.6 months, range 22-96 months). • Before surgery, patients were evaluated by physical examination, translabial ultrasonography, flexible cystoscopy, urodynamics, 1-hour pad test and compilation of a quality-of-life questionnaire. • Postoperatively, based on the physical examination and pad test, patients were stratified into three groups: (i) Cured: perfectly dry patients at stress test, pad weight 0-1 g; (ii) Improved: patients with mild to moderate incontinence, pad weight 2-50 g; and (iii) Failed: unchanged or worsened patients, pad weight >50 g.
• At the final follow-up visit, 26 (86.0%) patients were cured, 2 (7.0%) were improved and 2 (7.0%) had failed. • In particular, the total mean pad weight decreased to 33.2 ± 15.6 (71%) and the total mean questionnaire score significantly increased to 86.9 ± 6.7 (74.0%). • Sling tension readjustment was needed during follow-up in two patients (7%). • Among the complications, persistent urinary retention (10%), seroma formation (3%) and de novo urgency (7%) were easily treated.
• The Remeex system produced remarkable 5-year results with a low complication rate. These outcomes have also been confirmed in a worse prognosis patient group as reported in the present study.
• 回顾性报告固定尿道真性内括约肌缺陷(ISD)所致压力性尿失禁(SUI)患者行尿道下 2cm 耻骨后间隙植入可调节尿道吊带(Remeex 系统)的客观和主观疗效。
• 2002 年 5 月至 2008 年 7 月,30 例因医源性 ISD 导致严重 SUI 的女性患者接受了 Remeex 系统定位(平均随访 60.6 个月,范围 22-96 个月)。• 术前,通过体格检查、经阴道超声、软性膀胱镜检查、尿动力学、1 小时垫试验和生活质量问卷进行评估。• 术后,根据体格检查和垫试验,患者分为三组:(i)治愈:压力试验时完全无尿失禁患者,垫重 0-1g;(ii)改善:轻度至中度尿失禁患者,垫重 2-50g;(iii)失败:无变化或加重患者,垫重>50g。
• 末次随访时,26 例(86.0%)患者治愈,2 例(7.0%)患者改善,2 例(7.0%)患者失败。• 特别是,总平均垫重减少至 33.2±15.6(71%),总平均问卷评分显著增加至 86.9±6.7(74.0%)。• 2 例患者(7%)在随访期间需要调整吊带张力。• 在并发症中,持续性尿潴留(10%)、血清肿形成(3%)和新发急迫性尿失禁(7%)容易治疗。
• Remeex 系统产生了显著的 5 年疗效,且并发症发生率较低。本研究报告的预后较差的患者组也证实了这一结果。